Altogether, in the light of previous studies, the findings of the present study indicate a potentially important role of ADAM17 in determining the risk of severe COVID-19 and suggest that the selective inhibition of ADAM17 in humans could be a potential therapeutic approach, but this warrants further investigation. The gene discussed is ADAM17; the disease is COVID-19.